Hydroxyzine and Benadryl are both sedating antihistamines. They share many similarities but have different approved uses, ...
Purpose: The association of antipsychotic and antidepressant drugs with Q-T interval prolongation is reviewed. Summary: Prolongation of the Q-T interval can be of particular concern to ...
Everyone is encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088. You can also contact BioXcel Therapeutics, Inc. at 1-833-201 ...
Pfizer Inc. (NYSE: PFE) today announced positive topline results from the progression-free survival (PFS) analysis of the Phase 3 BREAKWATER study of ...
Roden [7] compiled a list of factors that may increase the likelihood of a patient developing Q-T interval prolongation and subsequent progression to TdP, such as female sex, hypokalemia ...
Pfizer Inc. today announced positive topline results from the progression-free survival (PFS) analysis of the Phase 3 BREAKWATER study of BRAFTOVI® (encorafenib) in combination with cetuximab ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results